Consensus JD Health International Inc.

Equities

6618

KYG5074A1004

Drug Retailers

Market Closed - Hong Kong S.E. Other stock markets 04:08:06 16/02/2026 GMT			5-day change	1st Jan Change
60.65 ^HKD	+0.58%		+2.54%	+9.28%

01-02	JD Health Surges Amid China's Healthcare Boom
12-22	China Merchants Securities (Hong Kong) Starts JD Health International at Buy	MT

Evolution of the Average Target: JD Health International Inc.

Evolution of the Target Price: JD Health International Inc.

Changes in Analyst Recommendations: JD Health International Inc.

cafb30d856a9763364.sacJ_1-TCzVeSShdnw4SgdTGG8AENUNQN04qq9RR9RA._dJemW7bMloTDGAs9UxD26GsK_FIRhMzcTRv34Unmj3W7G6eKqdnRREvSw~2484b6e70cb5a4068e9db48113043efa

Analysts' recommendations: JD Health International Inc.

12-22	China Merchants Securities (Hong Kong) Starts JD Health International at Buy	MT
11-17	Nomura Adjusts JD Health International's Price Target to HK$80 From HK$72, Keeps at Buy	MT
18/08/25	Nomura Adjusts JD Health International's Price Target to HK$72 From HK$52, Keeps at Buy	MT
15/08/25	Macquarie Upgrades JD Health International to Outperform from Underperform; Price Target is HK$62.14	MT
15/08/25	Jefferies Adjusts JD Health International's Price Target to HK$88 From HK$60, Keeps at Buy	MT
11/06/25	Jefferies Adjusts JD Health International's Price Target to HK$60 From HK$46, Keeps at Buy	MT
15/05/25	Nomura Adjusts JD Health International's Price Target to HK$44 From HK$41.50, Keeps at Buy	MT
10/03/25	Nomura Adjusts JD Health International's Price Target to HK$41.50 From HK$31, Keeps at Buy	MT
18/11/24	Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	MT
19/08/24	Nomura Adjusts JD Health International's Price Target to HK$25 From HK$37, Keeps at Buy	MT
17/07/24	Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target is HK$20.40	MT
22/03/24	Nomura Adjusts JD Health’s Price Target to HK$44 to HK$37, Keeps at Buy	MT
19/01/24	Nomura Adjusts JD Health International’s Price Target to HK$44 from HK$60, Keeps at Buy	MT
18/08/23	Nomura Adjusts JD Health's Price Target to HK$60 From HK$75, Keeps at Buy	MT
15/05/23	Nomura Adjusts JD Health's Price Target to HK$75 From HK$87, Keeps at Buy	MT
10/01/23	Nomura Adjusts JD Health's Price Target to HK$87 From HK$84, Keeps at Buy	MT
23/11/22	Nomura Adjusts JD Health International's Price Target to HK$84 From HK$70, Keeps at Buy	MT
11/04/22	UBS Adjusts JD Health International's Price Target to HK$70 From HK$138, Keeps at Buy	MT
30/03/22	Nomura Adjusts JD Health International's Price Target to HK$70 From HK$82, Keeps at Buy	MT
12/01/22	Nomura Starts JD Health International at Buy With HK$82 Price Target	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
JD HEALTH INTERNATIONAL INC.			+31.9%
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED			+13.19%
MATSUKIYOCOCOKARA & CO.			+22.04%
CLICKS GROUP LIMITED			+31.8%
YIFENG PHARMACY CHAIN CO., LTD.			+33.89%
NAHDI MEDICAL COMPANY			+30.1%
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.			+24.02%
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-	-	+168.88%
GUARDIAN PHARMACY SERVICES, INC.			+4.6%
DIS-CHEM PHARMACIES LIMITED			+7.99%
Average			+36.84%
Weighted average by Cap.			+31.39%